SOCS3 and FAM20 genes are significantly up-regulated in peripheral blood mononuclear cells during the acute phase of STEMI.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for SOCS3/FAM20 as acute STEMI biomarkers; leaves open clinical utility pending validation.
In the acute phase of STEMI, dozens of genes from several pathways linked with lipid/glucose metabolism, platelet function and atherosclerotic plaque stability show altered expression. Up-regulation of SOCS3 and FAM20 genes in the first days of myocardial infarction is observed in the vast majority of patients.
No takes yet. Share an insight, caveat, or question.
Kiliszek et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: